OTS193320

Catalog No.: A26762
SUV39H2 Inhibitor
OTS193320 is an imidazo[1,2-a]pyridine compound that acts as a selective inhibitor of the SUV39H2 methyltransferase. It effectively reduces global histone H3 lysine 9 tri-methylation levels in breast cancer cells, leading to apoptosis. Additionally, the combination of OTS193320 with Doxorubicin has been shown to significantly decrease γ-H2AX levels and enhance the reduction in cancer cell viability compared to the use of either compound alone. This makes OTS193320 a valuable tool for understanding the role of histone modifications in cancer therapy.
Grouped product items
Size Price Stock Qty
5mg
$310.00
In stock
10mg
$520.00
In stock
25mg
$1,010.00
In stock
50mg
$1,280.00
In stock
100mg
$1,895.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionOTS193320 is an imidazo[1,2-a]pyridine compound that acts as a selective inhibitor of the SUV39H2 methyltransferase. It effectively reduces global histone H3 lysine 9 tri-methylation levels in breast cancer cells, leading to apoptosis. Additionally, the combination of OTS193320 with Doxorubicin has been shown to significantly decrease γ-H2AX levels and enhance the reduction in cancer cell viability compared to the use of either compound alone. This makes OTS193320 a valuable tool for understanding the role of histone modifications in cancer therapy.
Product Information
Catalog NumA26762
FormulaC28H30ClN5O4
Molecular Weight536.02
CAS Number2093401-33-1
SMILESO=[N+](C1=CC=C(CN[C@@H]2CC[C@H](NC3=CC4=NC(C5=CC(Cl)=C(OC)C=C5OC)=CN4C=C3)CC2)C=C1)[O-]
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2